Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Oral isotretinoin effectively stabilizes frontal fibrosing alopecia.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Chronic stress and high cortisol levels can cause hair loss by disrupting hair growth.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Using both vertical and transverse sections gives a better diagnosis of alopecia than using one method alone.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

EVG staining is the most reliable method for diagnosing alopecia.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

White and yellow dots indicate severe female hair loss in dark skin.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Women with cicatricial hair loss may have a higher risk of hypertension.

Minoxidil helps stimulate hair growth and enlarge small follicles in common hair loss, but doesn't stop it, and its effects can be boosted when combined with finasteride.

People with alopecia have a higher risk of thyroid cancer.

Some botanical products may help increase hair growth in people with alopecia, but more research is needed.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Intradermal injections improve hair density and thickness better, while derma roller is more convenient.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.